Ukko's mission is to improve the lives of people with food allergies and sensitivities. Ukko uses immunology, machine learning, and protein engineering to make measurably better and safer proteins for use in food and therapeutics. Ukko does this by designing and controlling the molecular interactions between allergen proteins and the immune system.
Ukko's technology uses samples from patients and machine learning to guide the engineering of superior proteins that can be incorporated into food products and therapeutics. These proteins maintain or improve beneficial properties (taste, nutritional value, yield, and physicochemical and mechanical properties) but do not trigger an immune response. Ukko's initial product pipeline includes celiac-safe gluten proteins, allergy-safe and therapeutic peanut proteins, as well as a pipeline of additional allergen proteins.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Ukko Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 20, 2025
www.themarker.com
זו אינה אי־נוחות, אלא סכנת חיים. ייתכן שסטארט־אפ ישראלי מצא פתרון
undefined
Nov 2, 2021
www.calcalist.co.il
"פיתחנו גלוטן בטוח עבור חולי צליאק שמספרם מכפיל את עצמו כל כמה שנים" כלכליסט
#Customers
Apr 14, 2021
www.haaretz.com
The Israeli startup trying to reimagine wheat
#Investment #Expand
Jan 27, 2021
www.calcalistech.com
Ukko raises $40 million to develop solutions for food allergies and sensitivities
#Investment #Expand
Jan 27, 2021
www.calcalistech.com
Ukko raises $40 million to develop solutions for food allergies and sensitivities